April 2, 2026

Science Chronicle

A Science and Technology Blog

April 2, 2026

Science Chronicle

A Science and Technology Blog

COVID-19

CoronavirusCOVID-19Public HealthSARS-CoV-2Seroprevalence

Pune coronavirus sero survey results find 51.5% seroprevalence

  The sero survey carried out in five zones in Pune has found 51.5% seroprevalence, with the spread ranging from

Read More
CoronavirusCOVID-19DiagnosticsSARS-CoV-2Testing

FDA approves rapid, inexpensive saliva test for coronavirus

A rapid, inexpensive saliva test developed by Yale School of Public Health in partnership with NBA has high sensitivity. The

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2

Novel coronavirus-specific nutralising antibodies last at least for six months

  The researchers found that neutralizing antibodies were over 70% even at the end of six months. While IgG showed

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2

SARS-CoV-2-specific T cell immunity prevents recurrent severe COVID-19 disease

  The immune system elicits robust, broad and highly functional memory T cell responses once a person is infected with

Read More
Clinical trialCoronavirusCOVID-19Public HealthSARS-CoV-2Vaccines

Interim results of phase-1-2 trials find inactivated coronavirus vaccine is safe

  Interim results of Phase-1 and Phase-2 trials of an inactivated SARS-CoV-2 vaccine carried out in China show that the

Read More
CoronavirusCOVID-19EducationIndiaPublic HealthSARS-CoV-2

Reopening schools in India before coronavirus spread is reduced can be disastrous

  At a time when coronavirus cases in India are showing a rising trend and when daily fresh cases reported

Read More
ChinaCoronavirusCOVID-19EthicsPublic HealthSARS-CoV-2Vaccine hesitancyVaccines

Why Russia’s rushed-up coronavirus vaccine is mired in ethical, safety landmine

  Russia registering a vaccine for novel coronavirus even before beginning a Phase-3 trial and promising to  begin full-scale production

Read More
CoronavirusCOVID-19Herd immunityPublic HealthSARS-CoV-2

T cell memory that cross-reacts with novel coronavirus does not prevent infection, researcher clarifies

  The presence of pre-existing T cell memory against four common cold coronaviruses which cross-reacts with novel coronavirus may not

Read More
Aerosol transmissionCoronavirusCOVID-19MaskPublic HealthSARS-CoV-2

Two-layered polypropylene mask doubly better than a single-layered cotton mask, study finds

While fitted N95 masks allowed zero droplets to pass through, the three-layered surgical masks too performed very well with 0-10%

Read More
CoronavirusCOVID-19ICMRPublic HealthSARS-CoV-2Testing

COVID-19: India needs to ramp up testing but shouldn’t over-rely on rapid antigen tests

  With over 60,000 daily fresh cases, India has been reporting the highest numbers in the world for the last

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2

Nearly 100,000 children in the U.S. infected with coronavirus in just two weeks

  Nearly 1,00,000 (97,078 to be specific) children were infected with novel coronavirus in just two weeks during the period

Read More
CoronavirusCOVID-19Herd immunityPublic HealthSARS-CoV-2Vaccines

Is there a case for issuing immunity certificates to COVID-19 recovered people?

  While there is a clear case for ‘immunity passports’ with some restrictions for people who have recovered from COVID-19,

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2Viral load

Asymptomatic people carry same amount of coronavirus as those with symptoms

  A study has found that people who are infected with novel coronavirus but don’t exhibit symptoms carry the same

Read More